Press "Enter" to skip to content

Patent delisted for Purdue Pharma drug TARGINIQ

1
Copyright © DrugPatentWatch. Originally published at Patent delisted for Purdue Pharma drug TARGINIQ

Annual Drug Patent Expirations for TARGINIQ
Targiniq is a drug marketed by Purdue Pharma Lp and is included in one NDA. There are fifteen patents protecting this drug.

Drug patent litigation for TARGINIQ.

This drug has two hundred and sixty-two patent family members in forty-four countries.

The generic ingredient in TARGINIQ is naloxone hydrochloride; oxycodone hydrochloride. Additional details are available on the naloxone hydrochloride; oxycodone hydrochloride profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at Patent delisted for Purdue Pharma drug TARGINIQ
    Get the DrugPatentWatch Daily Briefing

    ✓ Patent Expirations and Generic Entry

    ✓ Insightful Articles & Case Studies

    ✓ Patent Litigation & Challenges

    ✓ 505(b)(2) & Biosimilars

    ✓ Industry Trends

    Do NOT follow this link or you will be banned from the site!